openPR Logo
Press release

Harness the power of your immune system with dendritic cells

02-17-2025 09:13 AM CET | Health & Medicine

Press release from: IMMU

IMMUMEDIC Limited (© IMMUMEDIC Limited)

IMMUMEDIC Limited (© IMMUMEDIC Limited)

In modern medicine, the understanding of the immune system and its role in the
fight against cancer is becoming increasingly important. Dendritic cells, a key component of our immune system
immune system, play a crucial role in this. These specialized immune cells are responsible for
responsible for recognizing foreign structures such as tumour cells and activating the immune system. But what
does this mean for patients suffering from cancer? And how can dendritic cells contribute to remission?
contribute to remission?
Cancer refers to a variety of diseases in which healthy tissue is replaced by diseased and degenerated
tissue, which leads to uncontrolled cell proliferation. The disease is one of the most common
causes of death worldwide, second only to cardiovascular disease. A central problem in the fight against
cancer is metastasis, in which malignant tumor cells invade neighboring tissues and organs. This is where
This is where dendritic cells come into play: they are able to identify tumor cells and initiate an immune response
immune response aimed at eliminating these cells.
Research shows that targeted activation of dendritic cells has the potential to promote remission in cancer patients.
cancer patients. Through innovative therapies aimed at strengthening these cells, patients may be able to
patients may be able to gain better control over their disease. For example, clinical
clinical trials have shown that dendritic cell therapies in combination with other immunotherapeutic approaches have
promising results in the treatment of certain tumor types. This opens up new perspectives
and hope for patients who find themselves in a challenging health situation.
For more information on the role of dendritic cells in the fight against cancer and the latest
developments in immunotherapy, please contact an:info@dendritische-zelltherapie-deutschland.com

Germany

https://www.dendritic-cell-therapy.eu

IMMUMEDIC Limited - Your partner for medical logistics and immunotherapy
Dear medical professionals and patients

We at IMMUMEDIC Limited are proud to be at your side as an international medical service provider. With our many years of expertise and as a cooperation partner with GMP-certified laboratories based in Europe, we are the leading partner for your needs in immunotherapy for cancer diagnosis and autoimmune diseases.

Our aim is to work with you to find the best solutions for your patients. That is why we offer you the therapeutic options of special cells (DCs), including autologous vaccines for immunological cancer therapy and defect drugs to combat metastases and apoptosis in the cancer cell. These high-quality therapies are produced individually from the blood of your customers/patients to enable customized treatment.

But our vision goes beyond therapy options - we want to ensure that you and your patients have access to our innovative therapy options at all times. That's why we have developed a revolutionary medical transportation logistics system that represents a milestone in our business policy. With the help of these logistics, we can deliver or facilitate the necessary blood collection kits and therapies quickly and efficiently.

We understand the value of time in medical practice. That's why we guarantee punctual processing and a smooth workflow so that you can concentrate fully on treating your patients. Our logistics experts work closely with you to find customized solutions for your individual requirements.

At IMMUMEDIC Limited, we put people first. We are passionate about ensuring that your patients receive the best possible care and that their quality of life is improved. With our innovative medical technology and highly skilled team, we want to help ensure that cancer diagnoses and autoimmune diseases are no longer seen as insurmountable hurdles.

Together we can achieve great things - let's join forces in the fight against these diseases and give your patients new treatment options.
Contact us today and discover the benefits of partnering with IMMUMEDIC Limited!

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Harness the power of your immune system with dendritic cells here

News-ID: 3870697 • Views:

More Releases from IMMU

Cancer in the workplace: How companies can support employees
07-28-2025 | Health & Medicine
IMMU
Cancer in the workplace: How companies can support employees
Supporting employees during their illness - and why this is also economically worthwhile A cancer diagnosis changes life abruptly - not only for those affected, but also for those around them. The workplace in particular plays a central role during this time. More and more companies are realizing that actively supporting sick employees is not only a human gesture, but can also make good business sense. Health is an economic factor Around half
Treatment of metastases
05-31-2025 | Health & Medicine
IMMU
Treatment of metastases
As an affected patient, you are aware of one thing: when you are diagnosed with cancer, everything changes, from your quality of life to your everyday life. Surgical removal of the primary tumor is often attempted. If this does not work, radiotherapy or chemotherapy is tried, and hormone therapy is also used for certain types of cancer. Most doctors who do not work scientifically are skeptical of the new forms
**The cancer clock is ticking - A ray of hope in the fight against tumors and metastases**
04-02-2025 | Health & Medicine
IMMU
**The cancer clock is ticking - A ray of hope in the fight against tumors and me …
Every year, over 600,000 people in Germany are diagnosed with cancer. Statistically, most people die from pancreatic cancer, lung cancer, breast cancer, bowel cancer, prostate cancer, glioblastoma, etc. Common therapeutic measures such as surgery, radiotherapy and chemotherapy are the gold standard in treatment. However, immunotherapy is becoming increasingly important to counteract these diverse challenges. However, it is important to know that not every immunotherapy is equally valuable. Some forms of
The key to fighting cancer: Dendritic cell therapy ?
03-23-2025 | Health & Medicine
IMMU
The key to fighting cancer: Dendritic cell therapy ?
In today's world, where we are constantly faced with new challenges in the field of cancer treatment, it is crucial to pursue innovative approaches. One promising method is therapy with tumor antigen-loaded dendritic cells. A functioning immune system plays a central role in fighting tumors and metastases. But how can we specifically support the immune system? Autologous dendritic cell therapy, produced from the blood of the affected patient, offers a promising

All 5 Releases


More Releases for IMMUMEDIC

07-28-2025 | Health & Medicine
IMMU
Cancer in the workplace: How companies can support employees
Supporting employees during their illness - and why this is also economically worthwhile A cancer diagnosis changes life abruptly - not only for those affected, but also for those around them. The workplace in particular plays a central role during this time. More and more companies are realizing that actively supporting sick employees is not only a human gesture, but can also make good business sense. Health is an economic factor Around half
05-31-2025 | Health & Medicine
IMMU
Treatment of metastases
As an affected patient, you are aware of one thing: when you are diagnosed with cancer, everything changes, from your quality of life to your everyday life. Surgical removal of the primary tumor is often attempted. If this does not work, radiotherapy or chemotherapy is tried, and hormone therapy is also used for certain types of cancer. Most doctors who do not work scientifically are skeptical of the new forms
04-02-2025 | Health & Medicine
IMMU
**The cancer clock is ticking - A ray of hope in the fight against tumors and me …
Every year, over 600,000 people in Germany are diagnosed with cancer. Statistically, most people die from pancreatic cancer, lung cancer, breast cancer, bowel cancer, prostate cancer, glioblastoma, etc. Common therapeutic measures such as surgery, radiotherapy and chemotherapy are the gold standard in treatment. However, immunotherapy is becoming increasingly important to counteract these diverse challenges. However, it is important to know that not every immunotherapy is equally valuable. Some forms of
01-12-2025 | Health & Medicine
IMMU
Can we still be cured? Can cancer be cured?
Dealing with the subject of cancer quickly reveals the complexity of this disease. The question of how to cure tumors and metastases is anything but simple. There are doctors who firmly believe in the golden standard - chemotherapy, radiotherapy or hormone therapy - and propagate these as universal solutions. Alternative therapies, on the other hand, are often stigmatized; when patients bring such approaches into play, the response is often to